Oya K, Nakamura Y, Shen LT, Ishizuki S, et al. Soluble PD-L1 predicts tumor response and immune-related adverse events in patients with advanced melanoma treated with anti-PD-1 antibodies. J Dermatol 2024 Mar 3. doi: 10.1111/1346-8138.17183.
PMID: 38433350